A quantitative structure-activity relationship study on matrix metalloproteinase inhibitors: Piperidine sulfonamide aryl hydroxamic acid analogs

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 22, Issue 1, 2007, Pages 23-27

  Kumaran, S ^a   Gupta, S P ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Inhibitors; Matrix metalloproteinase (MMP); Piperidine sulfonamide aryl hydroxamic acids; Quantitative structure activity relationship (QSAR)

Indexed keywords

CGS 27023A; CIPEMASTAT; COLLAGENASE 3; GELATINASE A; HYDROXAMIC ACID DERIVATIVE; MARIMASTAT; MATRIX METALLOPROTEINASE INHIBITOR; PIPERIDINE SULFONAMIDE ARYL HYDROXAMIC ACID DERIVATIVE; PRINOMASTAT; UNCLASSIFIED DRUG;

ARTICLE; CALCULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG POTENCY; DRUG STRUCTURE; ENZYME INHIBITION; HYDROGEN BOND; HYDROPHOBICITY; IC 50; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

HYDROXAMIC ACIDS; MATRIX METALLOPROTEINASES; PROTEASE INHIBITORS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33847760608     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360600956655     Document Type: Article

References (24)

1. Leung, D., Abbenante, G. and Fairlie, DP (2000) J Med Chem., 43, p. 305.
2. Babine, RE and Bender, SL (1997) Chem Rev, 97, p. 1359.
3. Ahrens, D., Koch, AE, Pope, RM, Steinpicarella, M. and Niedbala, MJ (1996) Arthritis Rheum, 39, p. 1576.
4. Blaser, J., Triebel, S., Maajosthusmann, U., Rimisch, J., Krahlmateblowski, U., Freudenberg, W., Fricke, R. and Tschesche, H. (1996) Clin Chim Acta, 244, p. 17.
5. Cawston, TE (1996) Pharmacol Ther, 70, p. 163.
6. Bramhall, SR (1997) Int J Pancreatol, 21, p. 1.
7. Lafleur, M., Underwood, JL, Rappolee, DA and Werb, Z. (1996) J Exp Med, 184, p. 2311.
8. Wojtowicz-Praga, SM, Dickson, RB and Hawkins, M. (1997) Invest New Drugs, 15, p. 61.
9. Cuzner, ML and Opdenakker, G. (1999) J Neuroimmunol, 94, p. 1.
10. Yong, VW, Krekoski, CA, Forsyth, PA, Bell, R. and Edwards, DR (1998) Trends Neurosci, 21, p. 75.
11. Matyszak, MK and Perry, VH (1996) J Neuroimmunol, 69, p. 141.
12. Coker, ML, Thomas, CV, Clair, MJ, Hendrick, JW, Krombach, SR, Galis, ZS and Spinale, FG (1998) Am J Physiol, 274, p. H1516.
13. Spinale, FG, Coker, ML, Krombach, SR, Mukherjee, R., Hallak, H., Houck, WV, Clair, MJ, Kribbs, SB, Johnson, LL, Peterson, JT and Zile, MR (1999) Circ Res, 85, p. 364.
14. Tyagi, SC (1998) Cardiovasc Pathol, 7, p. 153.
15. Lovejoy, B., Welch, AR, Carr, S., Luong, C., Broka, C., Hendricks, RT, Campbell, JA, Walker, AM, Martin, R., Van Wart, H. and Browner, MF (1999) Nat Struct Biol, 6, p. 217.
16. Burnett, D., Afford, SC, Campbell, EJ, Rios-Mollineda, RA, Buttle, DJ and Stockley, RA (1988) Clin Sci, 75, p. 601.
17. Finlay, GA, Russell, KJ, McMahon, KJ, D'Arcy, EM, Masterson, JB, FitzGerald, MX and O'Connor, CM (1997) Thorax, 52, p. 502.
18. Ohno, I., Ohtani, H., Nitta, Y., Suzuki, J., Hoshi, H., Honma, M., Isoyama, S., Tanno, Y., Tamura, G., Yamauchi, K., Nagura, H. and Shirato, K. (1997) Am J Respir Cell Mol Biol, 16, p. 212.
19. Palmgren, MS, deShazo, RD and Carter, RM (1992) J Allergy Clin Immunol, 4, p. 905.
20. Mitchell, PG, Magna, HA, Reeves, LM, Lopresti-Morow, LL, Yocum, SA, Rosner, PJ, Geoghegan, KF and Hambor, JE (1996) J Clin Invest, 97, p. 761.
21. Lohmander, LS, Neame, PJ and Sandy, JD (1993) Arthritis Rheum, 36, p. 1214.
22. Shalinsky, DR, Brekken, J., Zou, H., McDermott, CD, Forsyth, P., Edwards, D., Margosiak, S., Bender, S., Truitt, G., Wood, A., Varki, NM and Appelt, K. (1999) In inhibition of matrix metalloproteinases: Therapeutic applications, pp. 236-270. The New York Academy of Sciences, NY
23. Barta, TE, Becker, DP, Bedell, LJ, De Crescenzo, GA, McDonald, JJ, Mehta, P., Munie, GE and Villamil, CI (2000) Bioorg Med Chem Lett, 11, p. 2481.
24. Barta, TE, Becker, DP, Bedell, LJ, De Crescenzo, GA, McDonald, JJ, Munie, GE, Rao, S., Shieh, HS, Stegeman, R., Stevens, AM and Villamil, CI (2000) Bioorg Med Chem Lett, 10, p. 2815.